Yahoo Finance: Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock Morningstar: Hims & Hers reverses plan for oral Wegovy, and its stock tumbled 20% Hims & Hers reverses plan for oral Wegovy, and its stock tumbled 20% Pharmaceutical giant Novo Nordisk (NYSE: NVO) is planning to drastically reduce the list prices of its popular GLP-1 treatments, including Ozempic and Wegovy, next year.

Understanding the Context

The compa ... CNBC on MSN: Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison Fox Business: Novo Nordisk to slash list prices of Ozempic, Wegovy by up to 50%